Increased Norepinephrine Release Research Articles

Identification of a Locus Coeruleus-amygdala Angiotensinergic Circuit: Implications for Stress-related Cardiovascular Diseases

Background: The locus coeruleus (LC) is a significant noradrenergic nucleus in the brain sensitive to afferent interoceptive signals. It responds to behavioral challenges by increasing noradrenaline release through ascending projections to the hypothalamus, thalamus, cortex, and amygdala. The brain renin-angiotensin system (RAS) plays a role in stress-related cardiovascular diseases, and previous research has identified angiotensin II (Ang II) and its receptors in the LC. The current study aimed to gain a deeper understanding of the function of the Ang II type 1 receptor (AT1R) in the LC, particularly its involvement in transmitting interoceptive cardiovascular signals by regulating LC activity. Methods: Using AT1R-eGFP and AT1R-Cre mice combined with neuroanatomical tract-tracing, chemogenetic and behavioral approaches, we examined AT1R expressing neurons in the LC. Dual immunohistochemistry was used in AT1R-eGFP reporter mice to characterize LC-AT1R-eGFP+ cells by looking at the colocalization of noradrenergic neuron maker tyrosine hydroxylase (TH) and GFP. Cre-inducible tracing with AT1R-cre mice was applied for circuit anterograde analysis and in vivo chemogenetics were used for behavior testing and analysis. Results: The majority of AT1R-eGFP+ neurons (94%) in the LC were found to be co-localized with TH. By using anterograde labeling with cre-inducible GFP virus (AAV-DIO-GFP) in AT1R-Cre mice, it was revealed that the AT1R+ neurons in the LC predominantly project to the amygdala and extended amygdala regions. Only a few or no projections to other brain areas known to receive LC inputs were observed. Within the amygdala, the AT1R+ nerve terminals were specifically limited to the medial division of the central amygdala (CeM) and the basomedial amygdala (BMA). Subsequently, AT1R was deleted from LC by injecting Cre virus into AT1R-Flox mice. Although the general anxiety level remained unchanged, restraint stress-induced anxiety was attenuated following LC AT1R deletion as shown by increased open arm distance in the elevated plus maze (EPM) test (21.7±6.6mm AAV-GFP vs. 98.1±27.5mm AAV-Cre, p<0.05, n=10). Moreover, the study employed Cre-dependent inhibitory and excitatory designer receptors exclusively activated by designer drug (hM4Di and hM3Dq DREADD) with Clozapine-n-oxide (CNO) to selectively silence and activate the AT1R+ neurons in the LC. The inhibition of AT1R+ neurons decreased the baseline anxiety level in mice (36.6±8.6mm Saline vs. 153.4±38.9mm CNO, p<0.01, n=8, EPM open arm distance), while activation of AT1R+ neurons increased baseline anxiety level (963.1±223.1mm Saline vs. 408.5±92mm CNO, p<0.01, n=10, EPM open arm distance). Additionally, the acoustic startle response, which is associated with anxiety levels, was reduced after silencing the LC AT1R+ neurons (324±39.2mV Saline vs. 168.8±54.1mV CNO, p<0.05, n=8). Conclusion: These findings suggest that a specific group of angiotensinergic LC neurons sends projections to the amygdala, highlighting the potential significance of AT1R in mediating noradrenergic activation between the LC and amygdala. Future investigations will explore the response of LC AT1R+ neurons to stress-induced cardiovascular stimuli and afferent interoceptive LC inputs, which may offer novel insights, and new therapeutic direction for the link between stress disorders and cardiovascular disease risk. NIH 1R01HL137103-01A1. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Increased β2-adrenergic signaling promotes fracture healing through callus neovascularization in mice.

Traumatic brain injury (TBI) leads to skeletal changes, including bone loss in the unfractured skeleton, and paradoxically accelerates healing of bone fractures; however, the mechanisms remain unclear. TBI is associated with a hyperadrenergic state characterized by increased norepinephrine release. Here, we identified the β2-adrenergic receptor (ADRB2) as a mediator of skeletal changes in response to increased norepinephrine. In a murine model of femoral osteotomy combined with cortical impact brain injury, TBI was associated with ADRB2-dependent enhanced fracture healing compared with osteotomy alone. In the unfractured 12-week-old mouse skeleton, ADRB2 was required for TBI-induced decrease in bone formation and increased bone resorption. Adult 30-week-old mice had higher bone concentrations of norepinephrine, and ADRB2 expression was associated with decreased bone volume in the unfractured skeleton and better fracture healing in the injured skeleton. Norepinephrine stimulated expression of vascular endothelial growth factor A and calcitonin gene-related peptide-α (αCGRP) in periosteal cells through ADRB2, promoting formation of osteogenic type-H vessels in the fracture callus. Both ADRB2 and αCGRP were required for the beneficial effect of TBI on bone repair. Adult mice deficient in ADRB2 without TBI developed fracture nonunion despite high bone formation in uninjured bone. Blocking ADRB2 with propranolol impaired fracture healing in mice, whereas the ADRB2 agonist formoterol promoted fracture healing by regulating callus neovascularization. A retrospective cohort analysis of 72 patients with long bone fractures indicated improved callus formation in 36 patients treated with intravenous norepinephrine. These findings suggest that ADRB2 is a potential therapeutic target for promoting bone healing.

In vivo spontaneous activity and coital-evoked inhibition of mouse accessory olfactory bulb output neurons

Little is known about estrous effects on brain microcircuits. We examined the accessory olfactory bulb (AOB) invivo, in anesthetized naturally cycling females, as model microcircuit receiving coital somatosensory information. Whole-cell recordings demonstrate that output neurons are relatively hyperpolarized in estrus and unexpectedly fire high frequency bursts of action potentials. To mimic coitus, a calibrated artificial vagino-cervical stimulation (aVCS) protocol was devised. aVCS evoked stimulus-locked local field responses in the interneuron layer independent of estrous stage. The response is sensitive to α1-adrenergic receptor blockade, as expected since aVCS increases norepinephrine release in AOB. Intriguingly, only in estrus does aVCS inhibit AOB spike output. Estrus-specific output reduction coincides with prolonged aVCS activation of inhibitory interneurons. Accordingly, in estrus the AOB microcircuit sets the stage for coital stimulation to inhibit the output neurons, possibly via high frequency bursting-dependent enhancement of reciprocal synapse efficacy between inter- and output neurons.

Involvement of P2Y1, P2Y6, A1 and A2A Receptors in the Purinergic Inhibition of NMDA-Evoked Noradrenaline Release in the Rat Brain Cortex.

In the cerebral cortex, glutamate activates NMDA receptors (NMDARs), localized in noradrenergic neurons, inducing noradrenaline release that may have a permissive effect on glutamatergic transmission, and therefore, on the modulation of long-term plasticity. ATP is co-released with noradrenaline, and with its metabolites (ADP and adenosine) is involved in the purinergic modulation of electrically-evoked noradrenaline release. However, it is not known if noradrenaline release evoked by activation of NMDARs is also under purinergic modulation. The present study aimed to investigate and to characterize the purinergic modulation of noradrenaline release evoked by NMDARs. Stimulation of rat cortical slices with 30 µM NMDA increased noradrenaline release, which was inhibited by ATP upon metabolization into ADP and adenosine and by the selective agonists of A1 and A2A receptors, CPA and CGS2680, respectively. It was also inhibited by UTP and UDP, which are mainly released under pathophysiological situations. Characterization of the effects mediated by these compounds indicated the involvement of P2Y1, P2Y6, A1 and A2A receptors. It is concluded that, in the rat brain cortex, NMDA-evoked noradrenaline release is modulated by several purinergic receptors that may represent a relevant mechanism to regulate the permissive effect of noradrenaline on NMDA-induced neuroplasticity.

Vagal nerve activity and sympathetic nerve activity are suppressed by alpha-2 adrenergic receptor agonists in conscious rats

Vagal nerve activity (VNA) and sympathetic nerve activity (SNA) have been known to influence each other and changes in their activity directly, but details on this remain unknown. This study used an alpha-2 adrenergic receptor agonist (dexmedetomidine) to study how SNA affects VNA in the conscious state. Electroencephalography, electromyography, electrocardiography, cervical VNA, renal SNA, and catheters for arterial pressure measurement and intravenous drug administration were measured after male Wistar rats were anesthetized and implanted with electrodes. Dexmedetomidine (50 micro g/kg) was intravenously administered in conscious rats. Cervical VNA decreased and reached its lowest values about 10 min after intravenous dexmedetomidine administration. However, renal SNA, electromyography, and heart rate decreased immediately after administration, whereas arterial pressure increased immediately. These results show that alpha-2 adrenergic receptor agonists simultaneously inhibit VNA and SNA. Furthermore, the present data suggest that excessive SNA activation increases norepinephrine release, inducing an increase in the concentration of circulating norepinephrine, which in turn inhibits SNA via negative feedback and suppresses VNA. JST (JPMJMS2023) This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Activation of a Locus Coeruleus to Dorsal Hippocampus Noradrenergic Circuit Facilitates Associative Learning.

Processing of contextual information during a new episodic event is crucial for learning and memory. Neuromodulation in the hippocampus and prefrontal cortex plays an important role in the formation of associations between environmental cues and an aversive experience. Noradrenergic neurons in the locus coeruleus send dense projections to both regions, but their contribution to contextual associative learning has not been established. Here, we utilize selective optogenetic and pharmacological manipulations to control noradrenergic transmission in the hippocampus during the encoding of a contextual fear memory. We find that boosting noradrenergic terminal release in the dorsal CA1 enhances the acquisition of contextual associative learning and that this effect requires local activation of β-adrenenergic receptors. Moreover, we show that increasing norepinephrine release can ameliorate contextual fear learning impairments caused by dopaminergic dysregulation in the hippocampus. Our data suggest that increasing of hippocampal noradrenergic activity can have important implications in the treatment of cognitive disorders that involve problems in contextual processing.

Neural circuits of anxiolytic and antidepressant pherine molecules.

In this review, we describe proposed circuits mediating the mechanism of action of pherines, a new class of synthetic neuroactive steroids with demonstrated antianxiety and antidepressant properties, that engage nasal chemosensory receptors. We hypothesize that afferent signals triggered by activation of these peripheral receptors could reach subgroups of olfactory bulb neurons broadcasting information to gamma-aminobutyric acid (GABAergic) and corticotropin-releasing hormone (CRH) neurons in the limbic amygdala. We propose that chemosensory inputs triggered by pherines project to centrolateral (CeL) and centromedial (CeM) amygdala neurons, with downstream effects mediating behavioral actions. Anxiolytic pherines could activate the forward inhibitory GABAergic neurons that facilitate the release of neuropeptide S (NPS) in the locus coeruleus (LC) and GABA in the bed nucleus of the stria terminalis (BNST) and inhibit catecholamine release in the LC and ventral tegmental area (VTA) leading to rapid anxiolytic effect. Alternatively, antidepressant pherines could facilitate the CRH and GABAergic neurons that inhibit the release of NPS from the LC, increase glutamate release from the BNST, and increase norepinephrine (NE), dopamine (DA), and serotonin release from the LC, VTA, and raphe nucleus, respectively. Activation of these neural circuits leads to rapid antidepressant effect. The information provided is consistent with this model, but it should be noted that some steps on these pathways have not been demonstrated conclusively in the human brain.

Effects of the Endocannabinoid Anandamide on the Efficiency of Noradrenergic Neurotransmission in the Amygdaloid Body in Acute Stress in Mice

The effects of endocannabinoid neurotransmission on corticosterone secretion by the adrenals and release of noradrenaline in the amygdaloid body during acute stress modeled in the elevated platform test were studied by intracerebral microdialysis in C57Bl/6N mice using the CB1 receptor antagonist rimonabant and the anandamide reuptake inhibitor AM-404. Increases in corticosterone secretion on exposure to rimonabant (3 mg/kg, p.o.) confi rmed the role of CB1 receptors in controlling the activity of the hypothalamo-hypophyseal-adrenal (HHA) system and verifi ed their infl uences on the amplitude but not the duration of hormone secretion. Stress was accompanied by a transient increase in noradrenaline release in the amygdaloid body. AM-404 (3 mg/kg, i.p.) suppressed but did not fully inhibit stress-induced noradrenaline release, decreasing it to control levels. The results obtained here provide evidence that the endocannabinoid anandamide is involved in regulating presynaptic noradrenaline release in the amygdaloid body in conditions of psychological stress.

Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects

RationaleSchizophrenia is a mental illness which is characterised by positive and negative symptoms and by cognitive impairments. While the major prevailing hypothesis is that altered dopaminergic and/or glutamatergic transmission contributes to this disease, there is evidence that the noradrenergic system also plays a role in its major symptoms.ObjectivesIn the present paper, we investigated the pro-cognitive effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) an endogenous neuroprotective compound, on ketamine-modelled schizophrenia in rats.MethodsWe used an antagonist of NMDA receptors (ketamine) to model memory deficit symptoms in rats. Using the novel object recognition (NOR) test, we investigated the pro-cognitive effect of 1MeTIQ. Additionally, olanzapine, an atypical antipsychotic drug, was used as a standard to compare the pro-cognitive effects of the substances. In vivo microdialysis studies allowed us to verify the changes in the release of monoamines and their metabolites in the rat striatum.ResultsOur study demonstrated that 1MeTIQ, similarly to olanzapine, exhibits a pro-cognitive effect in NOR test and enhances memory disturbed by ketamine treatment. Additionally, in vivo microdialysis studies have shown that ketamine powerfully increased noradrenaline release in the rat striatum, while 1MeTIQ and olanzapine completely antagonised this neurochemical effect.Conclusions1MeTIQ, as a possible pro-cognitive drug, in contrast to olanzapine, expresses beneficial neuroprotective activity in the brain, increasing concentration of the extraneuronal dopamine metabolite, 3-methoxytyramine (3-MT), which plays an important physiological role in the brain as an inhibitory regulator of catecholaminergic activity. Moreover, we first demonstrated the essential role of noradrenaline release in memory disturbances observed in the ketamine-model of schizophrenia, and its possible participation in negative symptoms of the schizophrenia.

Distinct temporal integration of noradrenaline signaling by astrocytic second messengers during vigilance

Astrocytes may function as mediators of the impact of noradrenaline on neuronal function. Activation of glial α1-adrenergic receptors triggers rapid astrocytic Ca2+ elevation and facilitates synaptic plasticity, while activation of β-adrenergic receptors elevates cAMP levels and modulates memory consolidation. However, the dynamics of these processes in behaving mice remain unexplored, as do the interactions between the distinct second messenger pathways. Here we simultaneously monitored astrocytic Ca2+ and cAMP and demonstrate that astrocytic second messengers are regulated in a temporally distinct manner. In behaving mice, we found that while an abrupt facial air puff triggered transient increases in noradrenaline release and large cytosolic astrocytic Ca2+ elevations, cAMP changes were not detectable. By contrast, repeated aversive stimuli that lead to prolonged periods of vigilance were accompanied by robust noradrenergic axonal activity and gradual sustained cAMP increases. Our findings suggest distinct astrocytic signaling pathways can integrate noradrenergic activity during vigilance states to mediate distinct functions supporting memory.

Norepinephrine Might be a New Target on Vagus Nerve

Clinical and experimental studies have shown that vagus nerve stimulation (VNS) provides significant results in neurological diseases such as epilepsy, Parkinson disease, migraine and drug-resistant depression, but its molecular mechanism has not yet fully elucidated. It is known that the therapeutic effect of VNS is caused by the induction of noradrenergic neurons in Locus Coeruleus (LC) and thus increased norepinephrine (NE) release. It has been shown that the effect is achieved by the projections of the vagus nerve extending from the nucleus tract solitarius (NTS) to LC. In this opinion, it was suggested that instead of electrically stimulating the vagus nerve and indirectly increasing NE release, an NE release device that directly targets the NE foci must be developed. In this way, it is thought that the side effects of VNS can be ruled out and a stronger NE response might be obtained at the same time. Therefore, norepinephrine related pathways might be a new target on vagus nerve.

(R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism.

BackgroundAlthough recent studies provide insight into the molecular mechanisms of the effects of ketamine, the antidepressant mechanism of ketamine enantiomers and their metabolites is not fully understood. In view of the involvement of mechanisms other than the N-methyl-D-aspartate receptor in ketamine’s action, we investigated the effects of (R)-ketamine, (S)-ketamine, (R)-norketamine [(R)-NK], (S)-NK, (2R,6R)-hydroxynorketamine [(2R,6R)-HNK], and (2S,6S)-HNK on monoaminergic neurotransmission in the prefrontal cortex of mice.MethodsThe extracellular monoamine levels in the prefrontal cortex were measured by in vivo microdialysis.Results(R)-Ketamine and (S)-ketamine acutely increased serotonin release in a dose-dependent manner, and the effect of (R)-ketamine was greater than that of (S)-ketamine. In contrast, (S)-ketamine caused a robust increase in dopamine release compared with (R)-ketamine. Both ketamine enantiomers increased noradrenaline release, but these effects did not differ. (2R,6R)-HNK caused a slight but significant increase in serotonin and noradrenaline but not dopamine release. (S)-NK increased dopamine and noradrenaline but not serotonin release. Differential effects between (R)-ketamine and (S)-ketamine were also observed in a lipopolysaccharide-induced model of depression. An α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor antagonist, 2,3-dioxo-6-nitro-1,2,3,4- tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX), attenuated (S)-ketamine-induced, but not (R)-ketamine-induced serotonin release, whereas NBQX blocked dopamine release induced by both enantiomers. Local application of (R)-ketamine into the prefrontal cortex caused a greater increase in prefrontal serotonin release than that of (S)-ketamine.Conclusions(R)-Ketamine strongly activates the prefrontal serotonergic system through an AMPA receptor-independent mechanism. (S)-Ketamine-induced serotonin and dopamine release was AMPA receptor-dependent. These findings provide a neurochemical basis for the underlying pharmacological differences between ketamine enantiomers and their metabolites.

Dopamine and Norepinephrine Modulate the Formation of Aversive Memories in the Hippocampus

Aversive memories are important for survival, and dopaminergic signaling in the hippocampus has been implicated in aversive learning. However, the source and mode of action of hippocampal dopamine remain controversial. Here we combine optogenetic and pharmacological manipulations to control dopamine transmission in the hippocampus during encoding of contextual fear memory. We show in mice that hippocampal dopamine can potently modulate aversive memory formation during contextual fear conditioning. Using retrograde tracing, we identify a population of midbrain dopaminergic neurons near the border of the substantia nigra pars compacta and the lateral ventral tegmental area that send direct projections to the dorsal hippocampus. We separately demonstrate that activation of norepinephrine release in the hippocampus during encoding can also facilitate aversive memory formation. Moreover, we find that increasing norepinephrine release can ameliorate contextual fear learning impairments due to dopaminergic dysregulation in the hippocampus. Our findings identify a cluster of midbrain dopamine neurons that innervate the hippocampus, and we show that both dopamine from the midbrain and norepinephrine from the locus coeruleus modulate hippocampal contextual fear memory.

Exposure to hot and cold environments increases noradrenaline release in the bed nucleus of the stria terminalis in rats.

AimsThermoregulatory responses in homeothermic animals, including humans, are classified into involuntary autonomous and voluntary behavioral thermoregulatory responses. Although behavioral thermoregulatory responses are probably driven by positive (pleasant) and/or negative (unpleasant) emotions, the neuronal mechanisms underlying the induction of negative emotions by hot and cold environments remain poorly understood. The bed nucleus of the stria terminalis is a brain region implicated in stress responses and negative emotions, such as fear, anxiety, and aversion. Various stimuli that cause negative emotions, such as immobilization stress, fox odor, gastric distension, and inflammatory pain, increase noradrenaline release in the rat bed nucleus of the stria terminalis, especially in the ventral bed nucleus of the stria terminalis. It has been reported that the negative emotional component of pain is mediated by noradrenergic neurotransmission in the ventral bed nucleus of the stria terminalis. However, the role of intra‐ventral bed nucleus of the stria terminalis noradrenergic neurotransmission in the induction of negative emotion by exposure to hot and cold environments remains to be elucidated. For the first step to address this issue, the effects of hot and cold environments on noradrenaline release in the ventral bed nucleus of the stria terminalis were examined.MethodsIn vivo microdialysis analyses in unanesthetized, freely moving male Sprague‐Dawley rats were performed to examine hot and cold environments‐induced noradrenaline release in the ventral bed nucleus of the stria terminalis.ResultsExposure to hot (38°C) and cold (8°C) environments significantly increased noradrenaline release in the ventral bed nucleus of the stria terminalis.ConclusionsThe results suggest that exposure to hot and cold environments enhances noradrenergic neurotransmission in the ventral bed nucleus of the stria terminalis, which may induce negative emotion, and thereby drive avoidance behaviors, that is, escape from hot and cold environments.

Roles of noradrenergic transmission within the ventral part of the bed nucleus of the stria terminalis in bidirectional brain-intestine interactions.

AimsThe bed nucleus of the stria terminalis (BNST) is a limbic structure mediating autonomic and neuroendocrine responses and negative affective states such as anxiety and fear. We previously demonstrated that noradrenergic transmission via β‐adrenoceptors within the ventral part of BNST (vBNST) is involved in bidirectional interactions between the brain and the upper gastrointestinal (GI) tract. The present study aimed to examine the roles of intra‐vBNST noradrenergic transmission via β‐adrenoceptors in bidirectional interactions between the brain and lower GI tract.MethodsIn vivo microdialysis experiments were performed to examine colorectal distention (CRD)‐induced noradrenaline release within the vBNST of freely moving male Sprague‐Dawley rats. Colonic transit and abdominal pain perception were examined following intra‐vBNST injections of isoproterenol, a β‐adrenoceptor agonist, with and without co‐administration of timolol, a β‐adrenoceptor antagonist.ResultsCRD increased extracellular noradrenaline levels within the vBNST and evoked abdominal contractions in a pressure‐dependent manner (30‐60 mm Hg). Bilateral intra‐vBNST injections of isoproterenol (30 nmol/side) significantly increased CRD (30 mm Hg)‐induced abdominal contractions. Intra‐vBNST injections of isoproterenol (30 nmol/side) significantly increased colonic transit, which was reversed by co‐administration of timolol (30 nmol/side).ConclusionThe results of this study suggest (a) the existence of a positive feedback loop between intra‐vBNST noradrenaline release and abdominal pain perception, and (b) the modulation of colonic motility by intra‐vBNST noradrenergic transmission via β‐adrenoceptors. Dysfunction of the lower GI tract may increase noradrenaline release within the vBNST, which, in turn, may exacerbate impairment of its motility and pain perception.

External light activates hair follicle stem cells through eyes via an ipRGC–SCN–sympathetic neural pathway

Changes in external light patterns can alter cell activities in peripheral tissues through slow entrainment of the central clock in suprachiasmatic nucleus (SCN). It remains unclear whether cells in otherwise photo-insensitive tissues can achieve rapid responses to changes in external light. Here we show that light stimulation of animals' eyes results in rapid activation of hair follicle stem cells with prominent hair regeneration. Mechanistically, light signals are interpreted by M1-type intrinsically photosensitive retinal ganglion cells (ipRGCs), which signal to the SCN via melanopsin. Subsequently, efferent sympathetic nerves are immediately activated. Increased norepinephrine release in skin promotes hedgehog signaling to activate hair follicle stem cells. Thus, external light can directly regulate tissue stem cells via an ipRGC-SCN autonomic nervous system circuit. Since activation of sympathetic nerves is not limited to skin, this circuit can also facilitate rapid adaptive responses to external light in other homeostatic tissues.

Other Antidepressants.

Other Antidepressants.

Chapter 11 - Skin vasoconstriction as a heat conservation thermoeffector

Cold exposure stimulates heat production and conservation to protect internal temperature. Heat conservation is brought about via reductions in skin blood flow. The focus, here, is an exploration of the mechanisms, particularly in humans, leading to that cutaneous vasoconstriction. Local skin cooling has several effects: (1) reduction of tonic nitric oxide formation by inhibiting nitric oxide synthase and element(s) downstream of the enzyme, which removes tonic vasodilator effects, yielding a relative vasoconstriction; (2) translocation of intracellular alpha-2c adrenoceptors to the vascular smooth-muscle cell membrane, enhancing adrenergic vasoconstriction; (3) increased norepinephrine release from vasoconstrictor nerves; and (4) cold-induced vasodilation, seen more clearly in anastomoses-rich glabrous skin. Cold-induced vasodilation occurs in nonglabrous skin when nitric oxide synthase or sympathetic function is blocked. Reflex responses to general body cooling complement these local effects. Sympathetic excitation leads to the increased release of norepinephrine and its cotransmitter neuropeptide Y, each of which contributes significantly to the vasoconstriction. The contributions of these two transmitters vary with aging, disease and, in women, reproductive hormone status. Interaction between local and reflex mechanisms is in part through effects on baseline and in part through removal of the inhibitory effects of nitric oxide on adrenergic vasoconstriction.

Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity-resistant and obesity-prone rats

Previous studies have demonstrated a role for norepinephrine (NE) in energy regulation and feeding, and basal differences have been observed in hypothalamic NE systems in obesity-prone vs. obesity-resistant rats. Differences in the function of brain reward circuits, including in the nucleus accumbens (NAc), have been shown in obesity-prone vs. obesity-resistant populations, leading many researchers to explore the role of striatal dopamine in obesity. However, alterations in NE transmission also affect NAc mediated behaviors. Therefore, here we examined differences in striatal NE and the response to norepinephrine transporter blockers in obesity-prone and obesity-resistant rats. We found that striatal NE levels increase following systemic cocaine administration in obesity-prone, but not obesity-resistant rats. This could result from either blockade of striatal norepinephrine transporters (NET) by cocaine leading to reduced NE reuptake, or circuit-based responses following cocaine administration resulting in increased NE release. Retrodialysis of the NET inhibitor, desipramine, into the ventral striatum did not cause selective increases in striatal NE levels in obesity-prone rats, suggesting that circuit-based mechanisms underlie NE increases following systemic cocaine administration. Consistent with this, systemic desipramine treatment decreased locomotor activity in obesity-prone, but not obesity-resistant rats. Furthermore, obesity-prone rats were also more sensitive to desipramine-induced reductions in food intake compared to obesity-resistant rats. Taken together, these data expand our understanding of differences in NE systems of obesity-prone vs. resistant rats, and provide new insights into basal differences in striatal systems that may influence feeding behavior.

Thiol‐Oxidation Impairs Alpha2‐Adrenergic Receptor Mediated Inhibition of N‐type Ca2+ channels and Results in Receptor Mislocalization

IntroductionOxidative stress and sympathetic hyperactivity contribute to hypertension. In sympathetic neurons, activation of alpha2‐adrenergic receptors (α2AR) decreases nerve terminal release of norepinephrine (NE) by activating Gαi/o proteins to inhibit N‐type voltage‐gated Ca2+channels. We have shown in DOCA‐salt hypertensive rats that α2AR‐mediated inhibition of Ca2+channels is impaired in sympathetic neurons, resulting in increased NE release. Furthermore, blood pressure and α2AR function are preserved following treatment with clodronate (macrophage depletion agent) and apocynin (NADPH oxidase inhibitor). Oxidative stress is associated with adrenergic dysfunction and Gαi/o are targets of oxidative stress. Inhibition of α2AR‐Gαi/o coupling following pertussis toxin (PTX) treatment occurs due to ADP‐ribosylation on the C‐terminal cysteine (position 351) of Gαi/o. It is not known if thiol‐oxidation of this residue results in similar uncoupling. Therefore, we tested the hypothesis that oxidizing agents impair α2‐AR function by thiol‐oxidation of Cys351 on Gαi/o.MethodsThese studies used cultured sympathetic neurons, G1A1 cells (HEK cells stably expressing N‐type Ca2+ channels), and HEK 293T cells. Cell lines were co‐transfected with α2AR and either WT‐Gαo or PTX‐insensitive Gαo (PTXi‐Gαo, Cys351Gly). Oxidative stress was induced with H2O2, t‐BOOH, or diamide (thiol‐specific oxidant). Whole cell patch clamp was used to detect inhibition of Ca2+ current using NE to activate α2AR and GppNHp to inhibit Ca2+ current independent of α2AR activation. Immunohistochemistry was used to localize α2AR and Gαo following oxidant treatment before and after activation of α2AR with NE.ResultsIn sympathetic neurons, α2AR‐mediated inhibition of Ca2+ current was reduced following H2O2, t‐BOOH or diamide treatment vs. untreated neurons. GppNHp inhibited Ca2+ current equally in all neurons independent of oxidative stress. Oxidative stress impaired α2AR‐mediated inhibition of Ca2+ current similarly in G1A1 cells co‐transfected with WT‐Gαo or PTXi‐Gαo. Oxidative stress had no effect on cell capacitance or Ca2+ channel activity in neurons and G1A1 cells. In HEK 293T cells, oxidative stress did not affect co‐localization of α2AR and Gαo, however, oxidative stress resulted in greater cytoplasmic localization of α2AR.ConclusionsThiol‐oxidation results in impaired α2AR‐mediated inhibition of Ca2+ current. Thiol‐oxidation does not affect Gαo coupling to α2AR. Dysfunction may be attributed to thiol‐oxidation of cysteine residues on α2AR, which do not affect Gαo coupling, but may alter structural motifs that could affect receptor localization to the cell membrane.Support or Funding InformationSupported by NIH 2P01HL070687 and American Heart Association (15PRE25090218)